Kamada (KMDA) Change in Receivables (2012 - 2026)
Kamada (KMDA) reported Change in Receivables of $1.3 million for Q1 2026, up 291.95% on a YoY basis from $328611.4 in Q1 2025, and up 158.52% quarter-over-quarter from -$2.2 million in Q4 2025.
Kamada (KMDA) Change in Receivables (2012 - 2026) Analysis & Trends
Kamada has reported Change in Receivables for 15 years, with the latest figure at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 291.95% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at -$199000.0 (down 102.0% YoY), and the FY2025 full-year result was -$535000.0, down 190.22% from the prior year.
- Change in Receivables for Q1 2026 stood at $1.3 million, up from -$2.2 million in the prior quarter.
- The five-year high for Change in Receivables was $10.0 million in Q3 2024, with the low at -$3.9 million in Q4 2023.
- Historically, Change in Receivables has averaged $516277.1 across 5 years, with a median of $1362.0 in 2023.
- The largest YoY upside for Change in Receivables was 139354.98% in 2023 against a maximum downside of 110515.16% in 2023.
- Kamada's Change in Receivables stood at -$3495.0 in 2022, then slumped by 110515.16% to -$3.9 million in 2023, then surged by 77.78% to -$859000.0 in 2024, then plunged by 156.23% to -$2.2 million in 2025, then jumped by 158.52% to $1.3 million in 2026.
- The last three Change in Receivables figures came in at $1.3 million (Q1 2026), -$2.2 million (Q4 2025), and -$1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | -2.20 Mn |
| Dec 31, 2025 | -2.20 Mn |
| Sep 30, 2025 | -1.04 Mn |
| Sep 30, 2025 | -1.04 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | -671,000.00 |
| Mar 31, 2025 | -671,000.00 |
| Dec 31, 2024 | -859,000.00 |
| Dec 31, 2024 | -859,000.00 |
| Sep 30, 2024 | 10.00 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | -516,000.00 |
| Mar 31, 2024 | -516,000.00 |
| Dec 31, 2023 | -3.87 Mn |
| Dec 31, 2023 | -3.87 Mn |